This innovation holds the promise of a future where medicine is not just reactive but proactive, where treatments are not only effective but also tailored ... Jan 16
... Mar 30
Immutep was granted Fast Track designation for efti to treat 1st line HNSCC patients by the US FDA in early April 2021. ... Jul 12
BENLYSTA is the first medicine approved to treat systemic lupus and adults with active lupus nephritis, an important treatment advance for patients with this incurable ... Dec 18
Strategic collaboration for studying investigational treatments for patients with a variety of cancer types... Sep 05
-Advertisements-